CVE-2021-43935

Published: Dic 15, 2021 Last Modified: Nov 21, 2024 EU-VD ID: EUVD-2021-30797 Aliases: GSD-2021-43935
ExploitDB:
Other exploit source:
Google Dorks:
HIGH 8,1
Attack Vector: network
Attack Complexity: high
Privileges Required: none
User Interaction: none
Scope: unchanged
Confidentiality: high
Integrity: high
Availability: high
MEDIUM 6,8
Access Vector: network
Access Complexity: medium
Authentication: none
Confidentiality: partial
Integrity: partial
Availability: partial

Description

AI Translation Available

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

EPSS (Exploit Prediction Scoring System)

Trend Analysis

EPSS (Exploit Prediction Scoring System)

Prevede la probabilità di sfruttamento basata su intelligence sulle minacce e sulle caratteristiche della vulnerabilità.

EPSS Score
0,0020
Percentile
0,4th
Updated

EPSS Score Trend (Last 91 Days)

287

Improper Authentication

Draft
Common Consequences
Security Scopes Affected:
Integrity Confidentiality Availability Access Control
Potential Impacts:
Read Application Data Gain Privileges Or Assume Identity Execute Unauthorized Code Or Commands
Applicable Platforms
Technologies: ICS/OT, Not Technology-Specific, Web Based
View CWE Details
288

Authentication Bypass Using an Alternate Path or Channel

Incomplete
Common Consequences
Security Scopes Affected:
Access Control
Potential Impacts:
Bypass Protection Mechanism
Applicable Platforms
Technologies: Not Technology-Specific, Web Based
View CWE Details
Application

Welch Allyn Diagnostic Cardiology Suite by Baxter

cpe:2.3:a:baxter:welch_allyn_diagnostic_cardiology_suite:2.1.0:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
Application

Welch Allyn Vision Express Holter Analysis System by Baxter

Version Range Affected
From 6.1.0 (inclusive)
To 6.4.0 (inclusive)
cpe:2.3:a:baxter:welch_allyn_vision_express_holter_analysis_system:*:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
Operating System

Welch Allyn Q-Stress Cardiac Stress Testing System Firmware by Baxter

Version Range Affected
From 6.0.0 (inclusive)
To 6.3.1 (inclusive)
cpe:2.3:o:baxter:welch_allyn_q-stress_cardiac_stress_testing_system_firmware:*:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
Application

Welch Allyn Rscribe Resting Ecg System by Baxter

Version Range Affected
From 5.01 (inclusive)
To 7.0.0 (inclusive)
cpe:2.3:a:baxter:welch_allyn_rscribe_resting_ecg_system:*:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
Application

Welch Allyn Connex Cardio by Baxter

Version Range Affected
From 1.0.0 (inclusive)
To 1.1.1 (inclusive)
cpe:2.3:a:baxter:welch_allyn_connex_cardio:*:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
Operating System

Welch Allyn Xscribe Cardiac Stress Testing System Firmware by Baxter

Version Range Affected
From 5.01 (inclusive)
To 6.3.1 (inclusive)
cpe:2.3:o:baxter:welch_allyn_xscribe_cardiac_stress_testing_system_firmware:*:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
Operating System

Welch Allyn Hscribe Holter Analysis System Firmware by Baxter

Version Range Affected
From 5.01 (inclusive)
To 6.4.0 (inclusive)
cpe:2.3:o:baxter:welch_allyn_hscribe_holter_analysis_system_firmware:*:*:*:*:*:*:*:*
Common Platform Enumeration - Standardized vulnerability identification
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01
Mitigation Third Party Advisory US Government Resource
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01
Mitigation Third Party Advisory US Government Resource
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01